Studies demonstrated that exosomal HSP60 has high potential for clinical use, such as a potential clinical biomarker for diagnosing, monitoring disease progression, and assessing prognosis of a variety of cancers.260, 261, 262. The gene discussed is HSPD1; the disease is cancer.